163 related articles for article (PubMed ID: 32011733)
1. Theoretical potential for endometrial cancer prevention through primary risk factor modification: Estimates from the EPIC cohort.
Fortner RT; Hüsing A; Dossus L; Tjønneland A; Overvad K; Dahm CC; Arveux P; Fournier A; Kvaskoff M; Schulze MB; Bergmann M; Trichopoulou A; Karakatsani A; La Vecchia C; Masala G; Pala V; Mattiello A; Tumino R; Ricceri F; van Gils CH; Monninkhof EM; Bonet C; Quirós JR; Sanchez MJ; Rodríguez-Palacios DÁ; Gurrea AB; Amiano P; Allen NE; Travis RC; Gunter MJ; Viallon V; Weiderpass E; Riboli E; Kaaks R
Int J Cancer; 2020 Sep; 147(5):1325-1333. PubMed ID: 32011733
[TBL] [Abstract][Full Text] [Related]
2. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
3. An epidemiological model for prediction of endometrial cancer risk in Europe.
Hüsing A; Dossus L; Ferrari P; Tjønneland A; Hansen L; Fagherazzi G; Baglietto L; Schock H; Chang-Claude J; Boeing H; Steffen A; Trichopoulou A; Bamia C; Katsoulis M; Krogh V; Palli D; Panico S; Onland-Moret NC; Peeters PH; Bueno-de-Mesquita HB; Weiderpass E; Gram IT; Ardanaz E; Obón-Santacana M; Navarro C; Sánchez-Cantalejo E; Etxezarreta N; Allen NE; Khaw KT; Wareham N; Rinaldi S; Romieu I; Merritt MA; Gunter M; Riboli E; Kaaks R
Eur J Epidemiol; 2016 Jan; 31(1):51-60. PubMed ID: 25968175
[TBL] [Abstract][Full Text] [Related]
4. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers.
Michels KA; Pfeiffer RM; Brinton LA; Trabert B
JAMA Oncol; 2018 Apr; 4(4):516-521. PubMed ID: 29346467
[TBL] [Abstract][Full Text] [Related]
5. The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.
Laaksonen MA; Arriaga ME; Canfell K; MacInnis RJ; Byles JE; Banks E; Shaw JE; Mitchell P; Giles GG; Magliano DJ; Gill TK; Klaes E; Velentzis LS; Hirani V; Cumming RG; Vajdic CM
Gynecol Oncol; 2019 Jun; 153(3):580-588. PubMed ID: 30935715
[TBL] [Abstract][Full Text] [Related]
6. Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition.
Dossus L; Allen N; Kaaks R; Bakken K; Lund E; Tjonneland A; Olsen A; Overvad K; Clavel-Chapelon F; Fournier A; Chabbert-Buffet N; Boeing H; Schütze M; Trichopoulou A; Trichopoulos D; Lagiou P; Palli D; Krogh V; Tumino R; Vineis P; Mattiello A; Bueno-de-Mesquita HB; Onland-Moret NC; Peeters PH; Dumeaux V; Redondo ML; Duell E; Sanchez-Cantalejo E; Arriola L; Chirlaque MD; Ardanaz E; Manjer J; Borgquist S; Lukanova A; Lundin E; Khaw KT; Wareham N; Key T; Chajes V; Rinaldi S; Slimani N; Mouw T; Gallo V; Riboli E
Int J Cancer; 2010 Jul; 127(2):442-51. PubMed ID: 19924816
[TBL] [Abstract][Full Text] [Related]
7. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.
Bray F; Dos Santos Silva I; Moller H; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1132-42. PubMed ID: 15894663
[TBL] [Abstract][Full Text] [Related]
8. Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study.
AlHilli MM; Dowdy SC; Weaver AL; St Sauver JL; Keeney GL; Mariani A; Podratz KC; Bakkum-Gamez JN
Gynecol Oncol; 2012 Apr; 125(1):109-13. PubMed ID: 22210467
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2).
Cote ML; Alhajj T; Ruterbusch JJ; Bernstein L; Brinton LA; Blot WJ; Chen C; Gass M; Gaussoin S; Henderson B; Lee E; Horn-Ross PL; Kolonel LN; Kaunitz A; Liang X; Nicholson WK; Park AB; Petruzella S; Rebbeck TR; Setiawan VW; Signorello LB; Simon MS; Weiss NS; Wentzensen N; Yang HP; Zeleniuch-Jacquotte A; Olson SH
Cancer Causes Control; 2015 Feb; 26(2):287-296. PubMed ID: 25534916
[TBL] [Abstract][Full Text] [Related]
10. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
[TBL] [Abstract][Full Text] [Related]
11. On the epidemiology of oral contraceptives and disease.
Prentice RL; Thomas DB
Adv Cancer Res; 1987; 49():285-401. PubMed ID: 3314396
[TBL] [Abstract][Full Text] [Related]
12. Cancer risks and the contraceptive pill. What is the evidence after nearly 25 years of use?
Khoo SK
Med J Aust; 1986 Feb; 144(4):185-90. PubMed ID: 3511357
[TBL] [Abstract][Full Text] [Related]
13. [Oral contraceptives and endometrial and ovarian carcinomas].
Medl M
Gynakol Geburtshilfliche Rundsch; 1998; 38(2):105-8. PubMed ID: 9815528
[TBL] [Abstract][Full Text] [Related]
14. Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition.
Friedenreich C; Cust A; Lahmann PH; Steindorf K; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S; Linseisen J; Rohrmann S; Boeing H; Pischon T; Tjønneland A; Halkjaer J; Overvad K; Mendez M; Redondo ML; Garcia CM; Larrañaga N; Tormo MJ; Gurrea AB; Bingham S; Khaw KT; Allen N; Key T; Trichopoulou A; Vasilopoulou E; Trichopoulos D; Pala V; Palli D; Tumino R; Mattiello A; Vineis P; Bueno-de-Mesquita HB; Peeters PH; Berglund G; Manjer J; Lundin E; Lukanova A; Slimani N; Jenab M; Kaaks R; Riboli E
Cancer Causes Control; 2007 May; 18(4):399-413. PubMed ID: 17297555
[TBL] [Abstract][Full Text] [Related]
15. A prospective clinical cohort study of women at increased risk for endometrial cancer.
Clarke MA; Long BJ; Sherman ME; Lemens MA; Podratz KC; Hopkins MR; Ahlberg LJ; Mc Guire LJ; Laughlin-Tommaso SK; Wentzensen N; Bakkum-Gamez JN
Gynecol Oncol; 2020 Jan; 156(1):169-177. PubMed ID: 31718832
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
[TBL] [Abstract][Full Text] [Related]
17. Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition.
Allen NE; Tsilidis KK; Key TJ; Dossus L; Kaaks R; Lund E; Bakken K; Gavrilyuk O; Overvad K; Tjønneland A; Olsen A; Fournier A; Fabre A; Clavel-Chapelon F; Chabbert-Buffet N; Sacerdote C; Krogh V; Bendinelli B; Tumino R; Panico S; Bergmann M; Schuetze M; van Duijnhoven FJ; Bueno-de-Mesquita HB; Onland-Moret NC; van Gils CH; Amiano P; Barricarte A; Chirlaque MD; Molina-Montes ME; Redondo ML; Duell EJ; Khaw KT; Wareham N; Rinaldi S; Fedirko V; Mouw T; Michaud DS; Riboli E
Am J Epidemiol; 2010 Dec; 172(12):1394-403. PubMed ID: 20961969
[TBL] [Abstract][Full Text] [Related]
18. Ovarian and endometrial cancers.
Mant JW; Vessey MP
Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives and breast cancer.
Jick H; Walker AM; Watkins RN; D'Ewart DC; Hunter JR; Danford A; Madsen S; Dinan BJ; Rothman KJ
Am J Epidemiol; 1980 Nov; 112(5):577-85. PubMed ID: 7435486
[TBL] [Abstract][Full Text] [Related]
20. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
